Monogram Orthopaedics, Inc. (MGRM)

USD 2.72

(-4.56%)

Market Cap (In USD)

93.32 Million

Revenue (In USD)

364.99 Thousand

Net Income (In USD)

-13.74 Million

Avg. Volume

185.62 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.53-4.9
PE
-
EPS
-
Beta Value
2.4712296
ISIN
US6097861081
CUSIP
609786108
CIK
1769759
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Benjamin Sexson C.F.A.
Employee Count
-
Website
https://www.monogramorthopedics.com
Ipo Date
2023-05-18
Details
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.